Results 241 to 250 of about 119,908 (286)

Biomimetic Bone Marrow Monocyte Membrane‐Fused Extracellular Vesicles for Targeted Therapy of Myocardial Infarction

Advanced Science, EarlyView.
This study develops a biomimetic delivery system (M‐hEV) by fusing monocyte membranes with extracellular vesicles for targeted therapy of damaged cardiac tissue. The system homes to injured myocardium through specific molecular pathways. In a myocardial infarction model, M‐hEV effectively accumulates in the heart, reduces infarct size, alleviates ...
Jiaxin Song, Hao Yang, Qiqi Zhang, Wenqin Zhou, Rui Wang, Yuxing Xie, Emeli Chatterjee, Guoping Li, Jizong Jiang, Qiulian Zhou, Cuimei Zhao   +10 more
wiley   +1 more source

Nanoparticle-mediated mRNA delivery for cancer, autoimmunity, and genetic diseases: a rapid review. [PDF]

Front Drug Deliv
Ugwu OP, Ogenyi FC, Basajja M, Ugwu CN, Mustafa MM, Okon MB.   +5 more
europepmc   +1 more source

Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope. [PDF]

Drug Des Devel Ther
Luhung A, Hasanah AN, Ramdhani D.
europepmc   +1 more source

Influence of Peptide-Based Chelator Sequences on HER2-Targeting Radiopeptide. [PDF]

J Pept Sci
Gupta S, Kumar M, Repaka KM, Das A, Kengar AA, Satpati D.   +5 more
europepmc   +1 more source

Trop-2.2-Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model. [PDF]

Clin Cancer Res
Pratt EC, Bauer D, Carter LM, Cornejo M, Carrasco SE, Kaminsky S, De Gregorio R, Loor A, Friedl O, Bolaender A, Chao G, Castanares MA, Collins EC, Lewis JS.   +13 more
europepmc   +1 more source

On-Resin DIAMSAR-Conjugated CD38-Targeted Peptides and Their Inverso and Dimeric-Inverso Analogs for PET Imaging of Multiple Myeloma. [PDF]

Bioconjug Chem
Sharma AK, Tang R, Zheleznyak A, Manion B, Teubner E, Prior JL, Bauer T, Dyer MR, Lees S, Kelly K, Shokeen M.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The biodistribution of metaiodobenzylguanidine

Seminars in Nuclear Medicine, 1992
M E T A I O D O B E N Z Y L G U A N I D I N E can be (MIBG) labeled with iodine-(123I) or 1311. The nearly ideal emission properties m a k e 1231 the preferred radionuclide? MIBG is a guanethidine analogue and was originally studied as a potential antihypertensive agent.
M T, Parisi, E D, Sandler, R S, Hattner
openaire   +2 more sources